誉衡药业：12月29日召开董事会会议

Group 1 - The core point of the article is that Yuheng Pharmaceutical (SZ 002437) held its seventh board meeting on December 29, 2025, to discuss the proposal for the first extraordinary shareholders' meeting of 2026 [1] - For the first half of 2025, Yuheng Pharmaceutical's revenue composition was as follows: chemical drugs accounted for 90.39%, traditional Chinese medicine for 9.38%, and other businesses for 0.22% [1] - As of the report, Yuheng Pharmaceutical's market capitalization was 6.9 billion yuan [1] Group 2 - The article also highlights a significant event involving Moutai distributors, where over 2,000 attendees gathered for a conference to discuss major changes related to Moutai's pricing and distribution [1] - Chairman Chen Hua emphasized that distributors can no longer rely on passive income [1]